Clinical Trials
3 trialsNCT03875144 2026-02-09
MESOTIP
Institut du Cancer de Montpellier - Val d'Aurelle
Phase 2 Suspended
NCT01356303 2016-05-13
TAXIS01
National Guard Health Affairs
Phase 2 Suspended
NCT01088620 2013-03-14
Panitumumab Plus Pemetrexed and Cisplatin (PemCisP) Versus PemCis in the First-line Treatment of Patients With Non-small Cell Lung Cancer
WiSP Wissenschaftlicher Service Pharma GmbH
Phase 2 Suspended